![Ligand Pharmaceuticals Incorporated logo](/logos/LGND.webp)
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
Overview | Financials
Company Name | Ligand Pharmaceuticals Incorporated |
Symbol | LGND |
Currency | USD |
Price | 101.14 |
Market Cap | 1,847,726,660 |
Dividend Yield | 0% |
52-week-range | 49.24 - 112.13 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Todd C. Davis Ph.D. |
Website | https://www.ligand.com |
An error occurred while fetching data.
About Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis;
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD